News with the tag "Biotech"

In the rapidly evolving world of technology and health, a significant discussion is underway that could impact how quickly new treatments reach patients. OpenAI, a leader in artificial intelligence research, is reportedly in talks with the U.S. Food and Drug Administration (FDA) regarding the potent...

Imagine a world where food recalls due to contamination are relics of the past. That’s the ambitious vision driving Spore.Bio, a Paris-based startup leveraging the power of machine learning to transform microbiology testing . Fresh off a $23 million Series A funding round, led by Singular, Spore.Bio...

Ethereum co-founder Vitalik butterin has made headlines again with his latest charitable move, transferring $1 million in USDC stablecoins to his biotech fund, Kanro. The fund, established last year, supports innovative biotech projects. Meme Coin Sales Drive Donation Buterin conducted multiple tran...

Cortex, the ASI Alliance’s first decentralized AI model, targets robotics, biotech and healthcare for domain-specific applications.

The decentralized science DAO supports healthcare efforts that might otherwise not attract sufficient funding and gives stakeholders a say in their management.

The European Union unveiled the Trusted Investors Network at a meeting in Athens, Greece, to attract venture capital to deep-tech sectors like biotechnology and AI.

Former Binance CEO Changpeng Zhao (CZ) has shared a personal update, reflecting on his recent experiences and future aspirations. He emphasized his intention to focus on various projects related to education, blockchain, artificial intelligence (AI), and biotechnology. Zhao expressed confidence that...

Bitcoiner Christian Angermayer claimed the United Kingdom’s latest tax proposal for non-doms would be a “huge mistake” and be “a bigger act of national self-harm than Brexit.”

OpenAI is partnering with Los Alamos National Laboratory, which conducts research in fields including national security, space exploration, renewable energy and medicine.

Humacyte Inc (NASDAQ: HUMA) opened close to 25% up on Monday after the Food & Drug Administration granted its ATEV a special advanced-therapy designation. Shares of the biotech firm are still down some 30% versus their year-to-date high. Why does it matter for Humacyte stock? The Acellular Tissue En...